Osteoporosis and osteopenia affect over 200 million people worldwide and result in $14 billion in health care costs annually in the US alone. With an increasing aging population it is estimated that the 67 million Americans will be afflicted by low bone mass by the year 2020. Post-menopausal women are by far the largest population that suffers from osteoporosis. Current treatments to prevent bone loss predominantly utilize pharmacologic agents that target osteoclast activity, but their long-term use can have unwanted side effects including increased risk of unusual fractures. Thus physicians and their patients are looking for novel prevention and treatment options. Available data support a role for pro-inflammatory cells and cytokines as therapeutic targets because of their role in mediating osteoclast maturation and activity during menopause. Intestine-bone signaling is demonstrated to contribute to the regulation of bone density, yet very little is known about how menopause impacts the intestine and the role that this could play in bone loss. We have identified, for the first time that estrogen deficiency (induced by ovariectomy, ovx) leads to intestinal inflammation and causes dysbiosis of the intestinal microbiota in mice. Most importantly, oral administration of a human derived probiotic, Lactobacillus reuteri ATCC PTA 6475, inhibits ovx induced intestinal changes, bone marrow T-cell changes and prevents bone loss in ovx mice. Based on our novel findings, we hypothesize that L. reuteri prevents ovx induced bone loss by reducing gut and bone inflammation. The following aims are proposed to elucidate the role of gut-bone interactions in ovx induced bone loss as well as the mechanisms of L. reuteri mediated microbiota changes that prevent osteoporosis.
AIM 1. Investigate the role of the intestinal microbiota in ovx induced bone loss.
AIM 2. Identify the host mechanisms by which L. reuteri 6475 prevents ovx induced bone inflammation and bone loss.
AIM 3. Establish the mechanistic basis of L. reuteri 6475 prevention of osteoporosis in ovx. Outcomes of our studies could provide a paradigm shift in understanding the role of gut-bone signaling axis in menopause and the role of estrogen in shaping our intestinal microbiota. Our findings will also provide the foundation for future clinical studies to determine the effectiveness of probiotics to maximize bone health in post-menopausal women.

Public Health Relevance

Osteoporosis and osteopenia affect over 200 million people worldwide and result in $14 billion in health care costs annually in the US alone. Our studies will elucidate how bacteria that reside in our intestine impact bone loss and how probiotic therapy can alleviate symptoms of osteoporosis in post-menopausal women.

Agency
National Institute of Health (NIH)
Institute
National Center for Complementary & Alternative Medicine (NCCAM)
Type
Research Project (R01)
Project #
5R01AT007695-02
Application #
8724342
Study Section
Special Emphasis Panel (ZAT1-SM (27))
Program Officer
Duffy, Linda C
Project Start
2013-09-01
Project End
2018-05-31
Budget Start
2014-06-01
Budget End
2015-05-31
Support Year
2
Fiscal Year
2014
Total Cost
$414,114
Indirect Cost
$144,333
Name
Michigan State University
Department
Microbiology/Immun/Virology
Type
Schools of Arts and Sciences
DUNS #
193247145
City
East Lansing
State
MI
Country
United States
Zip Code
48824
Lee, Taehyung; Lee, Eunhee; Arrollo, David et al. (2016) Non-Hematopoietic β-Arrestin1 Confers Protection Against Experimental Colitis. J Cell Physiol 231:992-1000
Collins, Fraser L; Irwin, Regina; Bierhalter, Hayley et al. (2016) Lactobacillus reuteri 6475 Increases Bone Density in Intact Females Only under an Inflammatory Setting. PLoS One 11:e0153180
Packiriswamy, Nandakumar; Steury, Michael; McCabe, Ian C et al. (2016) Bacterial Dose-Dependent Role of G Protein-Coupled Receptor Kinase 5 in Escherichia coli-Induced Pneumonia. Infect Immun 84:1633-41
Irwin, Regina; Raehtz, Sandi; Parameswaran, Narayanan et al. (2016) Intestinal inflammation without weight loss decreases bone density and growth. Am J Physiol Regul Integr Comp Physiol :ajpregu.00051.2016
Zhang, Jing; Motyl, Katherine J; Irwin, Regina et al. (2015) Loss of Bone and Wnt10b Expression in Male Type 1 Diabetic Mice Is Blocked by the Probiotic Lactobacillus reuteri. Endocrinology 156:3169-82
Sharma, D; Parameswaran, N (2015) Multifaceted role of β-arrestins in inflammation and disease. Genes Immun 16:499-513
Sharma, Deepika; Malik, Ankit; Steury, Michael D et al. (2015) Protective Role of β-arrestin2 in Colitis Through Modulation of T-cell Activation. Inflamm Bowel Dis 21:2766-77
Packiriswamy, N; Parameswaran, N (2015) G-protein-coupled receptor kinases in inflammation and disease. Genes Immun 16:367-77
Durairaj, Haritha; Steury, Michael D; Parameswaran, Narayanan (2015) Paroxetine differentially modulates LPS-induced TNFα and IL-6 production in mouse macrophages. Int Immunopharmacol 25:485-92
McCabe, Laura; Britton, Robert A; Parameswaran, Narayanan (2015) Prebiotic and Probiotic Regulation of Bone Health: Role of the Intestine and its Microbiome. Curr Osteoporos Rep 13:363-71

Showing the most recent 10 out of 13 publications